Magnetar Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Magnetar Financial’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$741K	Buy	+1,672	New	+$780K	0.01%	537
2025 Q4	–	Sell	-2,757	Closed	-$1.08M	–	1233
2025 Q3	$1.08M	Buy	+2,757	New	+$1.15M	0.01%	453
2023 Q1	–	Sell	-8,788	Closed	-$2.54M	–	733
2022 Q4	$2.54M	Buy	+8,788	New	+$2.68M	0.04%	367
2022 Q1	–	Sell	-81,724	Closed	-$17.9M	–	1544
2021 Q4	$17.9M	Buy	81,724 +17,487	+27%	+$3.4M	0.18%	123
2021 Q3	$11.7M	Sell	64,237 -825	-1%	-$161K	0.12%	184
2021 Q2	$13.1K	Buy	65,062 +30,865	+90%	+$6.46M	0.12%	164
2021 Q1	$7.35M	Sell	34,197 -15,513	-31%	-$3.41M	0.07%	253
2020 Q4	$11.7M	Buy	+49,710	New	+$11.4M	0.17%	142
2018 Q3	–	Sell	-1,537	Closed	-$261K	–	710
2018 Q2	$261K	Buy	+1,537	New	+$238K	﹤0.01%	417
2017 Q4	–	Sell	-3,212	Closed	-$488K	–	900
2017 Q3	$488K	Buy	+3,212	New	+$483K	0.01%	436
2016 Q4	–	Sell	-10,205	Closed	-$890K	–	375
2016 Q3	$890K	Buy	+10,205	New	+$964K	0.01%	283

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Magnetar Financial's VRTX Position: Q1 2026 in Review

Magnetar Financial opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2026: 1,672 shares worth $741K. The stake represents 0.01% of the portfolio and ranks #537 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in VRTX as recently as Q3 2025.

Magnetar Financial first reported a position in VRTX in Q3 2016 and has held it in 11 quarters since. The position peaked at $17.9M in Q4 2021. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Magnetar Financial held 1,672 shares of Vertex Pharmaceuticals worth $741K as of Q1 2026.
Vertex Pharmaceuticals was a new Magnetar Financial position in Q1 2026.
Vertex Pharmaceuticals made up 0.01% of Magnetar Financial's portfolio in Q1 2026, its #537 holding.
Magnetar Financial first reported a position in Vertex Pharmaceuticals in Q3 2016 and has held it in 11 quarters since.
Magnetar Financial's Vertex Pharmaceuticals position peaked at $17.9M in Q4 2021.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.